Dr. Deepak Agarwal, MD

Dr. Agarwal practices at Maplewood Surgery Center in Maplewood, Minnesota.

Dr. Agarwal's NPI, 1972919538, was assigned on July 3, 2014. Dr. Agarwal graduated from Indiana University School Of Medicine in 2014. Dr. Agarwal's Indiana license number on file is 01082225A.

Dr. Agarwal's primary practice is Maplewood Surgery Center, at 2945 Hazelwood Street Ste 300, Maplewood, MN 55109. The practice phone is (651) 471-9701.

Dr. Agarwal's primary practice is Maplewood Surgery Center in Maplewood, Minnesota. Dr. Agarwal is also affiliated with M Health Fairview Bethesda Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Agarwal to 5 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 10 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Agarwal is board certified in urology by the American Board of Urology. Dmand AI has Dr. Agarwal's licenses on file in 2 states: Indiana and Minnesota.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Agarwal treats.

CMS data shows 393 Medicare services from Dr. Agarwal across 11 procedure codes in 2024, for 186 Medicare patients. Medicare paid $41,245 for them.

CMS counts 186 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 84 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 67, with 43% women.

In 2024, Dr. Agarwal wrote 690 Medicare Part D claims for 230 patients. 87% of them were for generic drugs. CMS names the drug for 592 of them, across 16 drugs with 11 or more claims each, at $53,279 in total drug cost. In 2023, CMS named 464 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Agarwal for performance year 2024, reported as part of a group. Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agarwal as offering telehealth. CMS counts 20 procedures of prostate resection by Dr. Agarwal, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 38 papers to Dr. Agarwal, published from 2015 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Lasers, Solid-State, Prostatic Hyperplasia and Kidney Calculi. Dr. Agarwal has published most often in J Endourol. Dr. Agarwal's most frequent co-authors are Tim Large, MD, Charles Upshur Nottingham, MD and Boyd Ramsey Viers, MD.

CMS Open Payments shows 37 general payments to Dr. Agarwal from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 34% of the total. Richard Wolf Medical Instruments Corp. paid the most, $2,845.

Dmand AI lists 1 award for Dr. Agarwal.

Dr. Agarwal graduated from Indiana University School Of Medicine in 2014.

Dr. Agarwal is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.